Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice
Open Access
- 21 September 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19), 4680
- https://doi.org/10.3390/ijms20194680
Abstract
Hyperuricemia has been recognized as a risk factor for insulin resistance as well as one of the factors leading to diabetic kidney disease (DKD). Since DKD is the most common cause of end-stage renal disease, we investigated whether febuxostat, a xanthine oxidase (XO) inhibitor, exerts a protective effect against the development of DKD. We used KK-Ay mice, an established obese diabetic rodent model. Eight-week-old KK-Ay mice were provided drinking water with or without febuxostat (15 μg/mL) for 12 weeks and then subjected to experimentation. Urine albumin secretion and degrees of glomerular injury judged by microscopic observations were markedly higher in KK-Ay than in control lean mice. These elevations were significantly normalized by febuxostat treatment. On the other hand, body weights and high serum glucose concentrations and glycated albumin levels of KK-Ay mice were not affected by febuxostat treatment, despite glucose tolerance and insulin tolerance tests having revealed febuxostat significantly improved insulin sensitivity and glucose tolerance. Interestingly, the IL-1β, IL-6, MCP-1, and ICAM-1 mRNA levels, which were increased in KK-Ay mouse kidneys as compared with normal controls, were suppressed by febuxostat administration. These data indicate a protective effect of XO inhibitors against the development of DKD, and the underlying mechanism likely involves inflammation suppression which is independent of hyperglycemia amelioration.Funding Information
- Grant-in-Aid for Scientific Research (16K09791)
This publication has 40 references indexed in Scilit:
- Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid AccumulationPLOS ONE, 2012
- Xanthine Oxidoreductase Is Involved in Macrophage Foam Cell Formation and Atherosclerosis DevelopmentArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 DiabetesDiabetes Care, 2010
- Effect of lowering uric acid on renal disease in the type 2 diabeticdb/dbmiceAmerican Journal of Physiology-Renal Physiology, 2009
- High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 DiabetesClinical Journal of the American Society of Nephrology, 2008
- Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without HyperuricemiaNephron Physiology, 2008
- Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneysJournal Of Physiology-London, 2007
- Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in TaiwanKidney International, 2005
- Diabetic Hypouricemia as an Indicator of Clinical NephropathyAmerican Journal of Nephrology, 1990
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970